According to researchers from the Salk Institute, certain cannabinoids like THC may have the potential to treat dementia and Alzheimer's disease by removing harmful protein plaques in the brain that are associated with dementia disorders like Alzheimer's. These plaques interfere with cell communication and the delivery of nutrients between neurons. Researchers from the Salk Institute administered THC to altered laboratory-grown human neurons that formed plaques and found the cannabinoid effectively broke down the buildup of these plaques and reduced cell inflammation. Because the Salk Institute is federally funded, it faces huge research barriers when it comes to studying cannabis. That said, researchers hope the next steps will be to conduct trials on mice and then, if all goes well, move on to human clinical trials.
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.